PMID- 19934610
OWN - NLM
STAT- MEDLINE
DCOM- 20100126
LR  - 20201209
IS  - 1598-9992 (Print)
IS  - 1598-9992 (Linking)
VI  - 54
IP  - 5
DP  - 2009 Nov
TI  - [Guidelines of treatment for non-bleeding peptic ulcer disease].
PG  - 285-97
AB  - Over the past century, since the introduction of non steroidal anti-inflammatory 
      drugs (NSAID), antacid, histamine H2-receptor antagonists (H2RA), proton pump 
      inhibitors (PPI), and discovery of Helicobacter pylori infection, the paradigm of 
      peptic ulcer disease has changed with marked decrease in morbidity and mortality. 
      However, peptic ulcer disease still occupies a position as a major health problem 
      with increase of aged population and NSAIDs usage. In daily general practice, the 
      management of peptic ulcer disease is directed according to the presence of 
      bleeding or not. For non-bleeding peptic ulcer disease, proper acid suppression 
      and the correction of underlying causes such as Helicobacter pylori infection and 
      NSAID use is the main stay of treatment. Though a complete understanding of 
      pathophysiology and a perfect treatment strategy are still a challenge, this 
      guideline aims to provide practical recommendations based on evidences or 
      consensus of experts through in-depth literature review and expert meeting.
FAU - Cheung, Dae Young
AU  - Cheung DY
AD  - Department of Internal Medicine, The Catholic University of Korea School of 
      Medicine, Seoul National University Hospital, Seoul, Korea.
FAU - Jung, Hwoon Yong
AU  - Jung HY
FAU - Song, Ho June
AU  - Song HJ
FAU - Jung, Sung Woo
AU  - Jung SW
FAU - Jung, Hyun Chae
AU  - Jung HC
CN  - Korean College of Helicobacter and Upper Gastrointestinal Research
CN  - Korean Association of Gastroenterology
LA  - kor
PT  - Journal Article
PT  - Practice Guideline
PL  - Korea (South)
TA  - Korean J Gastroenterol
JT  - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
JID - 101189416
RN  - 0 (Antacids)
RN  - 0 (Anti-Inflammatory Agents, Non-Steroidal)
RN  - 0 (Anti-Ulcer Agents)
RN  - 0 (Histamine Antagonists)
RN  - 0 (Proton Pump Inhibitors)
RN  - U015TT5I8H (Bismuth)
SB  - IM
MH  - Antacids/toxicity
MH  - Anti-Inflammatory Agents, Non-Steroidal/toxicity
MH  - Anti-Ulcer Agents/therapeutic use
MH  - Bismuth/therapeutic use
MH  - Helicobacter Infections/diagnosis/drug therapy
MH  - Helicobacter pylori
MH  - Histamine Antagonists/therapeutic use
MH  - Humans
MH  - Peptic Ulcer/*drug therapy
MH  - Proton Pump Inhibitors/therapeutic use
EDAT- 2009/11/26 06:00
MHDA- 2010/01/27 06:00
CRDT- 2009/11/26 06:00
PHST- 2009/11/26 06:00 [entrez]
PHST- 2009/11/26 06:00 [pubmed]
PHST- 2010/01/27 06:00 [medline]
AID - 200911254 [pii]
AID - 10.4166/kjg.2009.54.5.285 [doi]
PST - ppublish
SO  - Korean J Gastroenterol. 2009 Nov;54(5):285-97. doi: 10.4166/kjg.2009.54.5.285.